HHS Slashes Health Data Rules to Unleash Tech Innovation Wave
Published Date: 12/29/2025
Proposed Rule
Summary
This new rule aims to cut red tape around health data technology, making it easier for developers and healthcare providers to innovate and share info. It fixes problems with confusing rules about blocking information and offers more flexibility, saving time and money. Comments on the proposal are open until February 27, 2026, so stakeholders can weigh in before changes take effect.
Analyzed Economic Effects
5 provisions identified: 5 benefits, 0 costs, 0 mixed.
Big Cut to Certification Requirements
The rule would remove 34 certification criteria, revise 7, and retain 19 currently in the ONC Certification Program. HHS estimates a present value of $1.53 billion in cost savings (2024 dollars, discounted at 7%) beginning in 2027 and also estimates $284,132 in reviewer costs for about 644 reviewers. The changes are intended to reduce time and administrative burden for certified health IT developers and clinicians.
Tighter Information-Blocking Rules
The proposal would revise information-blocking rules by removing the 'third party seeking modification' use condition from the Infeasibility Exception and revising or removing the 'manner exception exhausted' condition. It would also revise the Manner Exception to bar contracts that are not market rate, contracts of adhesion, or that contain unconscionable terms, and would remove the TEFCA Manner Exception (subpart D). These changes are framed to reduce misuse that withholds electronic health information (EHI) and to promote access, exchange, and use of EHI.
Definitions Now Cover Automated and AI Access
The proposal would revise the 'access' and 'use' definitions to explicitly include automated means of access, exchange, or use of EHI, 'including, without limitation, autonomous AI systems.' As an alternative, it would also consider similarly revising the 'exchange' definition. This change clarifies that automated and AI-driven access is within the scope of the information-blocking rules.
Adopt USCDI v3.1 and Remove Outdated Standards
The proposed rule would adopt United States Core Data for Interoperability (USCDI) version 3.1 at Sec. 170.213 and remove certain outdated standards referenced by certification criteria. In some cases, the rule would allow a standards transition period until January 1, 2027. These updates are intended to align the Certification Program with current interoperability priorities.
Less Real-World Testing and Reporting Burden
The proposal would descope the 'Real World Testing' Condition and Maintenance of Certification requirements and remove or limit 'Insights' reporting measures, limiting Insights reporting to the 'use of FHIR in apps through certified health IT' measure. These changes align with prior enforcement discretion notices and are intended to reduce reporting and testing burdens on health IT developers.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16414, Adoption and Foster Care Analysis and Reporting System
This document withdraws a proposed rule that was published in the Federal Register on January 11, 2008. The proposed rule would have amended the Adoption and Foster Care Analysis and Reporting System (AFCARS) regulations at 45 CFR 1355.40 and the appendices to Part 1355 to modify the requirements for States to collect and report data to ACF on children in out-of-home care and in subsidized adoption or guardianship arrangements with the State. This document also withdraws the provision of the 2008 proposed rule that implemented the AFCARS penalty requirements of the Adoption Promotion Act of 2003 (Pub. L. 108-145).
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14709, Patient Protection and Affordable Care Act, HHS Notice of Benefit and Payment Parameters for 2027; and Basic Health Program; Correction
This correction fixes some typos and technical mistakes in the 2027 health insurance rules under the Affordable Care Act. It mainly affects people and organizations involved in health coverage plans by clarifying when the rules take effect and restoring some important regulation details. These fixes take effect on July 20, 2026, ensuring smoother and clearer health plan operations next year.
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-12069, Medicare Program; Strengthening Oversight of Accrediting Organizations (AOs) and Preventing AO Conflicts of Interest, and Related Provisions
This new rule makes sure the groups that check Medicare providers play fair and follow clear rules to avoid conflicts of interest. It updates how psychiatric hospitals are reviewed and tightens rules for providers who lost their Medicare status but want back in. These changes affect Medicare providers and accrediting groups, start June 16, 2027, and aim to keep care safe and trustworthy.
Previous / Next Documents
Previous: 2025-23890, Health Data, Technology, and Interoperability: Patient Engagement, Information Sharing, and Public Health Interoperability; Withdrawal
The government is officially pulling back some health data rules they proposed last year, so those changes won’t happen for now. This affects healthcare tech companies, patients, and public health groups who were expecting new ways to share and protect health info. The withdrawal takes effect December 29, 2025, meaning no new costs or changes from these proposals will hit soon.
Next: 2025-23917, Required Use by Foreign Applicants and Patent Owners of a Patent Practitioner
Starting soon, foreign inventors and patent owners will need to work with a registered U.S. patent expert to file or manage their patents. This change helps the USPTO keep things fair, fight fraud, and match rules used in other countries. If you’re affected, get ready to team up with a licensed patent pro by early 2026—no extra fees mentioned yet, but don’t miss the January 28 comment deadline!